Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2466354016 | Moexipril hydrochloride 15mg/hydrochlorothiazide 12.5mg tablet (product) | en | Fully specified name | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 2472550010 | Moexipril hydrochloride 15mg/hydrochlorothiazide 12.5mg tablet | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 3468935017 | Product containing moexipril hydrochloride 15 mg and hydrochlorothiazide 12.5 mg/1 each oral tablet | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3486799019 | Product containing moexipril hydrochloride 15 mg and hydrochlorothiazide 12.5 mg/1 each oral tablet (clinical drug) | en | Fully specified name | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3501965015 | Moexipril hydrochloride 15 mg and hydrochlorothiazide 12.5 mg oral tablet | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3570019016 | Product containing only moexipril hydrochloride 15 mg and hydrochlorothiazide 12.5 mg/1 each oral tablet | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3570020010 | Product containing only moexipril hydrochloride 15 mg and hydrochlorothiazide 12.5 mg/1 each oral tablet (clinical drug) | en | Fully specified name | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3680860019 | Hydrochlorothiazide 12.5 mg and moexipril hydrochloride 15 mg oral tablet | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 3680861015 | Product containing precisely hydrochlorothiazide 12.5 milligram and moexipril hydrochloride 15 milligram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 3680862010 | Product containing precisely hydrochlorothiazide 12.5 milligram and moexipril hydrochloride 15 milligram/1 each conventional release oral tablet | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 108361501000001116 | Moexipril hydrochloride 15 mg and hydrochlorothiazide 12.5 mg oral tablet | en | Synonym | Active | Only initial character case insensitive | SNOMED CT United Kingdom Edition module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely hydrochlorothiazide 12.5 milligram and moexipril hydrochloride 15 milligram/1 each conventional release oral tablet | Is a | Product containing hydrochlorothiazide and moexipril hydrochloride | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely hydrochlorothiazide 12.5 milligram and moexipril hydrochloride 15 milligram/1 each conventional release oral tablet | Has active ingredient | Moexipril hydrochloride | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely hydrochlorothiazide 12.5 milligram and moexipril hydrochloride 15 milligram/1 each conventional release oral tablet | Has active ingredient | Hydrochlorothiazide | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely hydrochlorothiazide 12.5 milligram and moexipril hydrochloride 15 milligram/1 each conventional release oral tablet | Has manufactured dose form | Tablet | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely hydrochlorothiazide 12.5 milligram and moexipril hydrochloride 15 milligram/1 each conventional release oral tablet | Has manufactured dose form | Conventional release oral tablet | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely hydrochlorothiazide 12.5 milligram and moexipril hydrochloride 15 milligram/1 each conventional release oral tablet | Is a | Product manufactured as oral dose form | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely hydrochlorothiazide 12.5 milligram and moexipril hydrochloride 15 milligram/1 each conventional release oral tablet | Is a | Product containing hydrochlorothiazide in oral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely hydrochlorothiazide 12.5 milligram and moexipril hydrochloride 15 milligram/1 each conventional release oral tablet | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely hydrochlorothiazide 12.5 milligram and moexipril hydrochloride 15 milligram/1 each conventional release oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely hydrochlorothiazide 12.5 milligram and moexipril hydrochloride 15 milligram/1 each conventional release oral tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely hydrochlorothiazide 12.5 milligram and moexipril hydrochloride 15 milligram/1 each conventional release oral tablet | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely hydrochlorothiazide 12.5 milligram and moexipril hydrochloride 15 milligram/1 each conventional release oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely hydrochlorothiazide 12.5 milligram and moexipril hydrochloride 15 milligram/1 each conventional release oral tablet | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely hydrochlorothiazide 12.5 milligram and moexipril hydrochloride 15 milligram/1 each conventional release oral tablet | Has active ingredient | Hydrochlorothiazide | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely hydrochlorothiazide 12.5 milligram and moexipril hydrochloride 15 milligram/1 each conventional release oral tablet | Has basis of strength substance | Hydrochlorothiazide | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely hydrochlorothiazide 12.5 milligram and moexipril hydrochloride 15 milligram/1 each conventional release oral tablet | Has presentation strength numerator value | 12.5 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely hydrochlorothiazide 12.5 milligram and moexipril hydrochloride 15 milligram/1 each conventional release oral tablet | Has active ingredient | Moexipril hydrochloride | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely hydrochlorothiazide 12.5 milligram and moexipril hydrochloride 15 milligram/1 each conventional release oral tablet | Has basis of strength substance | Moexipril hydrochloride | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely hydrochlorothiazide 12.5 milligram and moexipril hydrochloride 15 milligram/1 each conventional release oral tablet | Has presentation strength numerator value | 15 | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely hydrochlorothiazide 12.5 milligram and moexipril hydrochloride 15 milligram/1 each conventional release oral tablet | Has unit of presentation | Tablet | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely hydrochlorothiazide 12.5 milligram and moexipril hydrochloride 15 milligram/1 each conventional release oral tablet | Has precise active ingredient | Hydrochlorothiazide | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely hydrochlorothiazide 12.5 milligram and moexipril hydrochloride 15 milligram/1 each conventional release oral tablet | Has precise active ingredient | Moexipril hydrochloride | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely hydrochlorothiazide 12.5 milligram and moexipril hydrochloride 15 milligram/1 each conventional release oral tablet | Is a | Product containing hydrochlorothiazide and moexipril in oral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely hydrochlorothiazide 12.5 milligram and moexipril hydrochloride 15 milligram/1 each conventional release oral tablet | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely hydrochlorothiazide 12.5 milligram and moexipril hydrochloride 15 milligram/1 each conventional release oral tablet | Is a | Product containing only hydrochlorothiazide and moexipril in oral dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely hydrochlorothiazide 12.5 milligram and moexipril hydrochloride 15 milligram/1 each conventional release oral tablet | Plays role | Diuretic therapeutic role | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely hydrochlorothiazide 12.5 milligram and moexipril hydrochloride 15 milligram/1 each conventional release oral tablet | Has basis of strength substance | Moexipril hydrochloride | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely hydrochlorothiazide 12.5 milligram and moexipril hydrochloride 15 milligram/1 each conventional release oral tablet | Has basis of strength substance | Hydrochlorothiazide | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely hydrochlorothiazide 12.5 milligram and moexipril hydrochloride 15 milligram/1 each conventional release oral tablet | Has precise active ingredient | Hydrochlorothiazide | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely hydrochlorothiazide 12.5 milligram and moexipril hydrochloride 15 milligram/1 each conventional release oral tablet | Has precise active ingredient | Moexipril hydrochloride | true | Inferred relationship | Existential restriction modifier | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR